Home / Inspections / 1075227

FDA Inspection 1075227 — Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals Limited — FEI 3005151215

The FDA completed an inspection of Emcure Pharmaceuticals Limited on October 30, 2018 in Pune. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 30, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pune (India)

Additional Details

Bioanalytical BA/BE

Facility

Other inspections at this facility

  • 1079858 (OAI Wed Feb 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1023101 (OAI Thu Aug 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 912371 (OAI Wed Feb 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 867389 (VAI Fri Feb 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 834734 (VAI Fri Apr 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources